You have not yet registered? Get your account for free.
Forgot Password? We will send you a reset link
22 October 2024
Half-yearly financial statements 2024
29 April 2024
Annual financial statements 2023
30 August 2023
Half-yearly financial statements 2023
5 May 2023
Annual financial statements 2022
28 October 2022
Half-yearly financial statements 2022
18 May 2022
Annual financial statements 2021
21 September 2021
Half-yearly financial statements 2021
17 May 2021
Annual financial statements 2020
29 September 2020
Half-yearly financial statements 2020
25 May 2020
Annual financial statements 2019
24 September 2019
Halbjahresabschluss 2019
Half-yearly financial statements 2019
15 May 2019
Annual financial statements 2018
17 September 2018
Halbjahresabschluss 2018
28 May 2018
Jahresabschluss 2017
6 October 2017
Halbjahresabschluss 2017
24 May 2017
Jahresabschluss 2016
20 September 2016
Half-yearly financial statements 2016
19 November 2024
Formycon invites to earnings call on the nine-month results 2024 and announces participation in international investor conferences
18 November 2024
Formycon receives positive CHMP opinion for FYB203 (aflibercept), a biosimilar candidate to Eylea® under the tradenames AHZANTIVE® and Baiama®
15 November 2024
Aflibercept-Biosimilar FYB203 / AHZANTIVE®/ Baiama® receives positive CHMP Opinion from EMA
13 November 2024
25
Nov 24
Analysts’ Conference
28
Press Release – quarterly statement (call-date Q3)
